Please use this identifier to cite or link to this item: http://dspace.mediu.edu.my:8181/xmlui/handle/10419/3998
Full metadata record
DC FieldValueLanguage
dc.creatorBui, Thi Mai Van-
dc.creatorStolpe, Michael-
dc.date2007-
dc.date.accessioned2013-10-16T06:12:38Z-
dc.date.available2013-10-16T06:12:38Z-
dc.date.issued2013-10-16-
dc.identifierhttp://hdl.handle.net/10419/3998-
dc.identifierppn:527773581-
dc.identifier.urihttp://koha.mediu.edu.my:8181/xmlui/handle/10419/3998-
dc.descriptionThis paper studies the evolution of early retirement due to disease and injury in the German labor force between 1988 and 2004. Using data from the German Federation of Public Pension Providers, the IMS Health Drug Launches database and the WHO Mortality Database, we show that new drug launches have substantially helped to reduce the loss of labor at the disease-level over time. We employ a variety of econometric methods to exploit the pseudo-panel structure of our dataset and find that in Western Germany alone each new chemical entity has on average saved around 200 working years in every year of the observation period. Controlling for individual determinants of health-related retirement, such as worker?s age, sex and type of work, we also find evidence that the 2001 reform of pension laws has led to further reductions in the loss of labor from disease and injury.-
dc.languageeng-
dc.publisherKiel Institute for the World Economy (IfW) Kiel-
dc.relationKieler Arbeitspapiere 1317-
dc.rightshttp://www.econstor.eu/dspace/Nutzungsbedingungen-
dc.subjectI18-
dc.subjectJ26-
dc.subjectI12-
dc.subjectddc:330-
dc.subjectMedical technology-
dc.subjectEarly retirement-
dc.subjectRehabilitation services-
dc.subjectPension reform-
dc.subjectPseudo-panel data-
dc.subjectFlexible Altersgrenze-
dc.subjectErwerbsunfähigkeit-
dc.subjectPharmazeutisches Produkt-
dc.subjectTechnischer Fortschritt-
dc.subjectÄltere Arbeitskräfte-
dc.subjectArbeitsangebot-
dc.subjectRentenreform-
dc.subjectGesundheit-
dc.subjectSchätzung-
dc.subjectDeutschland-
dc.titleThe impact of new drug launches on the loss of labor from disease and injury: evidence from German panel data-
dc.typedoc-type:workingPaper-
Appears in Collections:EconStor

Files in This Item:
There are no files associated with this item.


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.